Back to Search Start Over

AUREOMYCIN: Experimental and Clinical Investigations

Authors :
BRYER, MORTON S.
SCHOENBACH, EMANUEL B.
CHANDLER, CAROLINE A.
BLISS, ELEANOR A.
LONG, PERRIN H.
Source :
JAMA: Journal of the American Medical Association; September 1948, Vol. 138 Issue: 2 p117-119, 3p
Publication Year :
1948

Abstract

Aureomycin is an antibiotic derived from a strain of Streptomyces aureofaciens. It is supplied as a yellow crystalline hydrochloride salt which is soluble in distilled water but somewhat less soluble in isotonic sodium chloride solutions. These solutions are acid (pH 4.5). The activity of the antibiotic deteriorates rapidly in alkaline solution at room temperature.IN VITRO STUDIESAureomycin has been shown to possess antibacterial activity against numerous gram-positive and gram-negative bacteria. Beta hemolytic streptococcic strains, groups A. D, F and G, and three strains of Streptococcus faecalis were susceptible to the effects of 0.3 to 1.25 micrograms of aureomycin per milliliter; Diplococcus pneumoniae types I, II and III were susceptible to 0.1 to 0.3 microgram, staphylococci to 0.6 microgram per milliliter, strains of Bacillus coli aerogenes to 5.0 micrograms per milliliter; Klebsiella pneumoniae to 1.0 to 5.0 micrograms per milliliter, Hemophilus influenzae to 2.0 micrograms per milliliter, and Brucella

Details

Language :
English
ISSN :
00987484 and 15383598
Volume :
138
Issue :
2
Database :
Supplemental Index
Journal :
JAMA: Journal of the American Medical Association
Publication Type :
Periodical
Accession number :
ejs28760115
Full Text :
https://doi.org/10.1001/jama.1948.02900020013004